Patent ID: 9295720
Filing Date: 2016-03-29
CPC Classification: A61K,A61P

Claim Text:
1. A method for therapy or for reducing recurrence of prostate cancer and/or for therapy or reducing occurrence of prostate cancer metastases in a male human subject in need thereof, comprising administering to the subject an effective amount of: (a) a purified human zona pellucida 3 (hZP3) glycoprotein, the amino acid backbone of which has the amino acid sequence SEQ ID NO:3; (b) purified hZP3 polypeptide, the sequence of which is SEQ ID NO:3; (c) a purified glycoprotein or polypeptide that is an allelic variant of (a) or (b); (d) an immunologically active fragment of the hZP3 glycoprotein of (a), or of the polypeptide of (b) or the allelic variant of (c), that comprises: or (e) an expression vector comprising a nucleic acid molecule that encodes (b), (c) or (d).